- AdventHealth
The AdventHealth Heart, Lung and Vascular Institute recently designed a new program, called the Comprehensive Atrial Fibrillation to help treat patients with long-standing Atrial Fibrillation (AFib) by combining a multidisciplinary approach and offering a minimally invasive procedure to improve, and potentially cure, the most common type of heart arrhythmia.
According to the National Library of Medicine, the success rate of this type of surgery is 60-80% globally.
HOW IT WORKS:
This FDA-approved hybrid approach involves two procedures – a catheter-based ablation and FDA-approved minimally-invasive epicardial ablation. This surgical treatment involves using thoracoscopic cameras to make small incisions in order to perform a surgical ablation, which historically would involve an open-heart surgery procedure.
“Instead of opening your chest and going inside the heart to fix AFib, we can make the same type of lesions on the outside of the heart using cameras to guide us, without stopping it, and only make a 2-centimeter incision at the base of your chest,” said Dr. David Spurlock, a cardiothoracic surgeon at AdventHealth Orlando.
The program works by electrophysiologists (EP) referring patients to Spurlock for the first procedure on the heart. Then, four to eight weeks later, the patient goes back to the electrophysiologist for the second minimally invasive procedure called an endocardial ablation.
“In this procedure, we ablate the inside of the heart by simply accessing veins in the legs, and the benefit of this hybrid approach with the surgeon ablating the outside of the heart and the electrophysiologist ablating the inside of the heart is that it in a group of patients with longstanding atrial fibrillation it increases the chances of being able to maintain normal rhythm long term” said Dr. Mahmoud Altawil, an electrophysiologist at AdventHealth Orlando.
In addition, because Dr. Spurlock clips the left atrial appendage during his portion of the procedure many of these patients will be able to come off blood thinners at some point which is another added benefit.
GO DEEPER:
To learn more about the new Comprehensive AFib program, click here.
For cardiologists and EPs at AdventHealth, this new program is currently available in Epic as “New Patient Consult with AFib.” All other physicians can contact AdventHealth Cardiovascular Surgery Orlando at Call407-425-1566 for more information or to discuss potential cases.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...